Search

Anthony H Nguyen

Examiner (ID: 17425)

Most Active Art Unit
2854
Art Unit(s)
3307, 2854, 2853
Total Applications
2014
Issued Applications
1600
Pending Applications
48
Abandoned Applications
337

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4825805 [patent_doc_number] => 20080124795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Vascular Cell Culture Patterning Substrate' [patent_app_type] => utility [patent_app_number] => 10/592199 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15699 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124795.pdf [firstpage_image] =>[orig_patent_app_number] => 10592199 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/592199
Vascular Cell Culture Patterning Substrate Mar 9, 2005 Abandoned
Array ( [id] => 5296073 [patent_doc_number] => 20090010999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Complex Particles and Coated Complex Particles' [patent_app_type] => utility [patent_app_number] => 10/591827 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17717 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010999.pdf [firstpage_image] =>[orig_patent_app_number] => 10591827 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/591827
Complex Particles and Coated Complex Particles Mar 9, 2005 Abandoned
Array ( [id] => 4904021 [patent_doc_number] => 20080113434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Serum-Free Suspension Culture System For Mesenchymal Progenitor Cells' [patent_app_type] => utility [patent_app_number] => 10/598597 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8210 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113434.pdf [firstpage_image] =>[orig_patent_app_number] => 10598597 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/598597
Serum-Free Suspension Culture System For Mesenchymal Progenitor Cells Mar 3, 2005 Abandoned
Array ( [id] => 5100768 [patent_doc_number] => 20070184030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Large scale storage of viable somatic stem and/or progenitor cells' [patent_app_type] => utility [patent_app_number] => 10/591409 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7467 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184030.pdf [firstpage_image] =>[orig_patent_app_number] => 10591409 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/591409
Large scale storage of viable somatic stem and/or progenitor cells Feb 27, 2005 Abandoned
Array ( [id] => 7051292 [patent_doc_number] => 20050187179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Apoptosis inducing agents and methods' [patent_app_type] => utility [patent_app_number] => 11/069208 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26400 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187179.pdf [firstpage_image] =>[orig_patent_app_number] => 11069208 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/069208
Apoptosis inducing agents and methods Feb 27, 2005 Abandoned
Array ( [id] => 5045568 [patent_doc_number] => 20070264241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Compounds for Enhanced Cancer Therapy' [patent_app_type] => utility [patent_app_number] => 10/588379 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16540 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264241.pdf [firstpage_image] =>[orig_patent_app_number] => 10588379 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/588379
Compounds for Enhanced Cancer Therapy Feb 24, 2005 Abandoned
Array ( [id] => 5178041 [patent_doc_number] => 20070179101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Immunostimulatory oligonucleotide that induces interferon alpha' [patent_app_type] => utility [patent_app_number] => 10/590761 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9449 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179101.pdf [firstpage_image] =>[orig_patent_app_number] => 10590761 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/590761
Immunostimulatory oligonucleotide that induces interferon alpha Feb 24, 2005 Issued
Array ( [id] => 8994814 [patent_doc_number] => 08518699 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Methods for genetic diversification in gene conversion active cells' [patent_app_type] => utility [patent_app_number] => 10/590211 [patent_app_country] => US [patent_app_date] => 2005-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 8858 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10590211 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/590211
Methods for genetic diversification in gene conversion active cells Feb 22, 2005 Issued
Array ( [id] => 4663612 [patent_doc_number] => 20080254519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Process for Producing Picolinic Acid Compounds' [patent_app_type] => utility [patent_app_number] => 10/591603 [patent_app_country] => US [patent_app_date] => 2005-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13760 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254519.pdf [firstpage_image] =>[orig_patent_app_number] => 10591603 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/591603
Process for Producing Picolinic Acid Compounds Feb 21, 2005 Abandoned
Array ( [id] => 4820715 [patent_doc_number] => 20080226720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Wound Healing Composition' [patent_app_type] => utility [patent_app_number] => 10/589227 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8611 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226720.pdf [firstpage_image] =>[orig_patent_app_number] => 10589227 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/589227
Wound healing composition Feb 13, 2005 Issued
Array ( [id] => 5028442 [patent_doc_number] => 20070269889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Stabilized siRNAs as transfection controls and silencing reagents' [patent_app_type] => utility [patent_app_number] => 11/051195 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 29080 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269889.pdf [firstpage_image] =>[orig_patent_app_number] => 11051195 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/051195
Stabilized siRNAs as transfection controls and silencing reagents Feb 3, 2005 Abandoned
Array ( [id] => 6952845 [patent_doc_number] => 20050227940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Amplifying interfering RNA (RNAi) expression and effects' [patent_app_type] => utility [patent_app_number] => 11/040098 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 11443 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227940.pdf [firstpage_image] =>[orig_patent_app_number] => 11040098 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/040098
Amplifying interfering RNA (RNAi) expression and effects Jan 23, 2005 Abandoned
Array ( [id] => 6967105 [patent_doc_number] => 20050234002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Antisense oligomers and methods for inducing immune tolerance and immunosuppression' [patent_app_type] => utility [patent_app_number] => 11/041164 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14286 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20050234002.pdf [firstpage_image] =>[orig_patent_app_number] => 11041164 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/041164
Antisense oligomers and methods for inducing immune tolerance and immunosuppression Jan 20, 2005 Abandoned
Array ( [id] => 7170045 [patent_doc_number] => 20050202541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Three component chimeric antisense oligonucleotides' [patent_app_type] => utility [patent_app_number] => 11/035693 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4477 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202541.pdf [firstpage_image] =>[orig_patent_app_number] => 11035693 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/035693
Three component chimeric antisense oligonucleotides Jan 13, 2005 Issued
Array ( [id] => 5739042 [patent_doc_number] => 20060009433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Neuroprotective spirostenol pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/031538 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 28832 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009433.pdf [firstpage_image] =>[orig_patent_app_number] => 11031538 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/031538
Neuroprotective spirostenol pharmaceutical compositions Jan 6, 2005 Abandoned
Array ( [id] => 4657583 [patent_doc_number] => 20080026444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Process For Producing Protein-Polymer Complex' [patent_app_type] => utility [patent_app_number] => 10/584447 [patent_app_country] => US [patent_app_date] => 2004-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7025 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20080026444.pdf [firstpage_image] =>[orig_patent_app_number] => 10584447 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/584447
Process For Producing Protein-Polymer Complex Dec 23, 2004 Abandoned
Array ( [id] => 6945259 [patent_doc_number] => 20050197308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Vaccines' [patent_app_type] => utility [patent_app_number] => 11/017103 [patent_app_country] => US [patent_app_date] => 2004-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9188 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197308.pdf [firstpage_image] =>[orig_patent_app_number] => 11017103 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/017103
Vaccines Dec 19, 2004 Abandoned
Array ( [id] => 6906370 [patent_doc_number] => 20050101765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Photocleavable protecting groups' [patent_app_type] => utility [patent_app_number] => 11/016380 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 11404 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101765.pdf [firstpage_image] =>[orig_patent_app_number] => 11016380 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/016380
Photocleavable protecting groups Dec 16, 2004 Abandoned
Array ( [id] => 6918120 [patent_doc_number] => 20050095681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Intracellular modulators of apoptopic cell death pathways' [patent_app_type] => utility [patent_app_number] => 11/012128 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 25840 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095681.pdf [firstpage_image] =>[orig_patent_app_number] => 11012128 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/012128
Intracellular modulators of apoptopic cell death pathways Dec 15, 2004 Abandoned
Array ( [id] => 159079 [patent_doc_number] => 07674617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'MiRNA molecules isolated from human embryonic stem cell' [patent_app_type] => utility [patent_app_number] => 10/582915 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9587 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674617.pdf [firstpage_image] =>[orig_patent_app_number] => 10582915 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582915
MiRNA molecules isolated from human embryonic stem cell Dec 14, 2004 Issued
Menu